| Active substance | Olorofim |
| Holder | Clinigen Healthcare Ltd on behalf of F2G Ltd |
| Status | Running |
| Indication | Treatment of invasive fungal infections for patients lacking alternative treatment options. |
| Public documents | Approbation |
| Last update | 26/05/2026 |
Olorofim
Last updated on